長期投資家のためのIR情報
バリュートレンド

【9776】札幌臨床検査センター 〔上場廃止〕
ー(上場廃止)調剤薬局、臨床検査。


東証スタンダード
サー
>
治験
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2026.03 2026/02/06 Q3予 20,688 → 0.0% 0.0% 775 → 0.0% 0.0% 771 → 0.0% 0.0% 505 → 0.0% 0.0%
2026.03 2025/11/07 Q2予 20,688 → 0.0% 0.0% 775 → 0.0% 0.0% 771 → 0.0% 0.0% 505 → 0.0% 0.0%
2026.03 2025/08/04 Q1予 20,688 → 0.0% 0.0% 775 → 0.0% 0.0% 771 → 0.0% 0.0% 505 → 0.0% 0.0%
2026.03 2025/05/12 当初予 20,688 - - - 775 - - - 771 - - - 505 - - -
2025.03 2025/05/12 実 20,131 → 0.0% +1.7% 706 → 0.0% +41.2% 707 → 0.0% +43.4% 464 → 0.0% +45.0%
2025.03 2025/05/07 修正予 20,131 ↑ +1.7% +1.7% 706 ↑ +41.2% +41.2% 707 ↑ +43.4% +43.4% 464 ↑ +45.0% +45.0%
2025.03 2025/02/12 Q3予 19,799 → 0.0% 0.0% 500 → 0.0% 0.0% 493 → 0.0% 0.0% 320 → 0.0% 0.0%
2025.03 2024/11/08 Q2予 19,799 → 0.0% 0.0% 500 → 0.0% 0.0% 493 → 0.0% 0.0% 320 → 0.0% 0.0%
2025.03 2024/08/05 Q1予 19,799 → 0.0% 0.0% 500 → 0.0% 0.0% 493 → 0.0% 0.0% 320 → 0.0% 0.0%
2025.03 2024/05/13 当初予 19,799 - - - 500 - - - 493 - - - 320 - - -
2024.03 2024/05/13 実 19,682 ↑ +0.6% +0.6% 534 ↓ -1.3% -1.3% 514 ↑ +5.8% +5.8% 380 ↑ +23.8% +23.8%
2024.03 2024/02/09 Q3予 19,556 → 0.0% 0.0% 541 → 0.0% 0.0% 486 → 0.0% 0.0% 307 → 0.0% 0.0%
2024.03 2023/11/10 Q2予 19,556 → 0.0% 0.0% 541 → 0.0% 0.0% 486 → 0.0% 0.0% 307 → 0.0% 0.0%
2024.03 2023/08/07 Q1予 19,556 → 0.0% 0.0% 541 → 0.0% 0.0% 486 → 0.0% 0.0% 307 → 0.0% 0.0%
2024.03 2023/05/12 当初予 19,556 - - - 541 - - - 486 - - - 307 - - -
2023.03 2023/05/12 実 20,127 ↑ +3.9% +3.9% 1,008 ↓ -13.5% -13.5% 1,159 ↑ +4.4% +4.4% 568 ↓ -20.4% -20.4%
2023.03 2023/02/10 Q3予 19,364 → 0.0% 0.0% 1,165 → 0.0% 0.0% 1,110 → 0.0% 0.0% 714 → 0.0% 0.0%
2023.03 2022/11/09 Q2予 19,364 → 0.0% 0.0% 1,165 → 0.0% 0.0% 1,110 → 0.0% 0.0% 714 → 0.0% 0.0%
2023.03 2022/08/08 Q1予 19,364 → 0.0% 0.0% 1,165 → 0.0% 0.0% 1,110 → 0.0% 0.0% 714 → 0.0% 0.0%
2023.03 2022/05/13 当初予 19,364 - - - 1,165 - - - 1,110 - - - 714 - - -
2022.03 2022/05/13 実 19,109 → 0.0% +9.7% 1,537 → 0.0% +79.8% 1,605 → 0.0% +67.7% 1,042 → 0.0% +81.5%
2022.03 2022/05/09 修正予 19,109 ↑ +9.7% +9.7% 1,537 ↑ +79.8% +79.8% 1,605 ↑ +67.7% +67.7% 1,042 ↑ +81.5% +81.5%
2022.03 2022/02/09 Q3予 17,414 → 0.0% 0.0% 855 → 0.0% 0.0% 957 → 0.0% 0.0% 574 → 0.0% 0.0%
2022.03 2021/11/08 Q2予 17,414 → 0.0% 0.0% 855 → 0.0% 0.0% 957 → 0.0% 0.0% 574 → 0.0% 0.0%
2022.03 2021/08/06 Q1予 17,414 → 0.0% 0.0% 855 → 0.0% 0.0% 957 → 0.0% 0.0% 574 → 0.0% 0.0%
2022.03 2021/05/14 当初予 17,414 - - - 855 - - - 957 - - - 574 - - -
2021.03 2021/05/14 実 17,502 → 0.0% +1.6% 1,142 → 0.0% +84.2% 1,188 → 0.0% +87.1% 793 → 0.0% +94.8%
2021.03 2021/05/07 修正予 17,502 ↑ +1.6% +1.6% 1,142 ↑ +84.2% +84.2% 1,188 ↑ +87.1% +87.1% 793 ↑ +94.8% +94.8%
2021.03 2021/02/08 Q3予 17,226 → 0.0% 0.0% 620 → 0.0% 0.0% 635 → 0.0% 0.0% 407 → 0.0% 0.0%
2021.03 2020/08/07 Q1予 17,226 → 0.0% 0.0% 620 → 0.0% 0.0% 635 → 0.0% 0.0% 407 → 0.0% 0.0%
2021.03 2020/05/13 当初予 17,226 - - - 620 - - - 635 - - - 407 - - -
2020.03 2020/05/13 実 17,659 ↑ +1.5% +1.5% 944 ↑ +14.6% +14.6% 982 ↑ +16.2% +16.2% 528 ↓ -4.3% -4.3%
2020.03 2020/02/12 Q3予 17,401 → 0.0% 0.0% 824 → 0.0% 0.0% 845 → 0.0% 0.0% 552 → 0.0% 0.0%
2020.03 2019/11/11 Q2予 17,401 → 0.0% 0.0% 824 → 0.0% 0.0% 845 → 0.0% 0.0% 552 → 0.0% 0.0%
2020.03 2019/08/05 Q1予 17,401 → 0.0% 0.0% 824 → 0.0% 0.0% 845 → 0.0% 0.0% 552 → 0.0% 0.0%
2020.03 2019/05/13 当初予 17,401 - - - 824 - - - 845 - - - 552 - - -
2019.03 2019/05/13 実 17,065 ↓ -5.0% -5.0% 815 ↓ -21.7% -21.7% 813 ↓ -23.2% -23.2% 523 ↓ -27.0% -27.0%
2019.03 2019/02/12 Q3予 17,972 → 0.0% 0.0% 1,041 → 0.0% 0.0% 1,058 → 0.0% 0.0% 716 → 0.0% 0.0%
2019.03 2018/11/09 Q2予 17,972 → 0.0% 0.0% 1,041 → 0.0% 0.0% 1,058 → 0.0% 0.0% 716 → 0.0% 0.0%
2019.03 2018/08/06 Q1予 17,972 → 0.0% 0.0% 1,041 - - - 1,058 → 0.0% 0.0% 716 → 0.0% 0.0%
2019.03 2018/05/11 当初予 17,972 - - - - - - - 1,058 - - - 716 - - -
2018.03 2018/05/11 実 - - - - - - - - - - - - - - - -
2018.03 2018/05/07 修正予 17,459 ↓ -1.3% -1.3% - - - - 1,053 ↑ +35.3% +35.3% 685 ↑ +31.2% +31.2%
2018.03 2018/02/13 Q3予 17,695 → 0.0% 0.0% 751 → 0.0% 0.0% 778 → 0.0% 0.0% 522 → 0.0% 0.0%
2018.03 2017/11/10 Q2予 17,695 → 0.0% 0.0% 751 → 0.0% 0.0% 778 → 0.0% 0.0% 522 → 0.0% 0.0%
2018.03 2017/08/07 Q1予 17,695 → 0.0% 0.0% 751 → 0.0% 0.0% 778 → 0.0% 0.0% 522 → 0.0% 0.0%
2018.03 2017/05/12 当初予 17,695 - - - 751 - - - 778 - - - 522 - - -
2017.03 2017/05/12 実 17,055 ↓ -3.6% -3.6% 771 ↑ +10.6% +10.6% 803 ↑ +10.5% +10.5% 513 ↑ +7.8% +7.8%
2017.03 2017/02/10 Q3予 17,685 → 0.0% 0.0% 697 → 0.0% 0.0% 727 → 0.0% 0.0% 476 → 0.0% 0.0%
2017.03 2016/11/11 Q2予 17,685 → 0.0% 0.0% 697 → 0.0% 0.0% 727 → 0.0% 0.0% 476 → 0.0% 0.0%
2017.03 2016/08/05 Q1予 17,685 → 0.0% 0.0% 697 → 0.0% 0.0% 727 → 0.0% 0.0% 476 → 0.0% 0.0%
2017.03 2016/05/13 当初予 17,685 - - - 697 - - - 727 - - - 476 - - -
2016.03 2016/05/13 実 17,528 ↓ -1.0% -1.0% 974 ↑ +16.8% +16.8% 999 ↑ +19.6% +19.6% 590 ↑ +10.9% +10.9%
2016.03 2016/02/09 Q3予 17,713 → 0.0% 0.0% 834 → 0.0% 0.0% 835 → 0.0% 0.0% 532 → 0.0% 0.0%
2016.03 2015/11/10 Q2予 17,713 → 0.0% 0.0% 834 → 0.0% 0.0% 835 → 0.0% 0.0% 532 → 0.0% 0.0%
2016.03 2015/08/05 Q1予 17,713 → 0.0% 0.0% 834 → 0.0% 0.0% 835 → 0.0% 0.0% 532 → 0.0% 0.0%
2016.03 2015/05/15 当初予 17,713 - - - 834 - - - 835 - - - 532 - - -
2015.03 2015/05/15 実 17,166 → 0.0% +0.5% 869 → 0.0% +36.0% 896 → 0.0% +38.5% 573 → 0.0% +45.4%
2015.03 2015/05/08 修正予 17,166 ↑ +0.5% +0.5% 869 ↑ +36.0% +36.0% 896 ↑ +38.5% +38.5% 573 ↑ +45.4% +45.4%
2015.03 2015/02/09 Q3予 17,083 → 0.0% 0.0% 639 → 0.0% 0.0% 647 → 0.0% 0.0% 394 → 0.0% 0.0%
2015.03 2014/11/05 Q2予 17,083 → 0.0% 0.0% 639 → 0.0% 0.0% 647 → 0.0% 0.0% 394 → 0.0% 0.0%
2015.03 2014/08/06 Q1予 17,083 → 0.0% 0.0% - - - - 647 → 0.0% 0.0% 394 → 0.0% 0.0%
2015.03 2014/05/13 当初予 17,083 - - - 639 - - - 647 - - - 394 - - -
2014.03 2014/05/13 実 16,549 - - - 905 - - - 933 - - - 493 - - -
シェア ツイート
ページトップへ戻る